In contrast, we proved that extended inhibition of CIP2A expression, SET-induced PP2A inhibition and PP2A-phosphorylation by FTY720 treatment caused a deeply antitumoral effect in breast cancer cells. The gene discussed is SET; the disease is breast cancer.